The FDA has approved an injectable antimicrobial for treatment and control of swine respiratory disease. Baytril 100, manufactured by Bayer Animal Health, works by killing all four major SRD-causing bacteria: Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis. The antimicrobial injectable product works quickly and delivers peak therapeutic drug concentrations from a single, subcutaneous injection behind the ear.

“The introduction of Baytril 100 to the swine market is important because it gives producers and veterinarians access to the unique mode of action of the fluoroquinolone class of antibiotics,” according to Cary Christensen, senior director at Bayer Animal Health. “We are very excited to bring the swine industry this new management tool to help improve herd health.”

Animals intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For more information, see www.Baytril100.com

Source: Bayer Animal Health